Cargando…
In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
Mutations arising in vivo in recorder genes of human blood cells provide biomarkers for molecular epidemiology by serving as surrogates for cancer-causing genetic changes. Current markers include mutations of the glycophorin-A (GPA) or hemoglobin (Hb) genes, measured in red blood cells, or mutations...
Autores principales: | Albertini, R J, Nicklas, J A, Fuscoe, J C, Skopek, T R, Branda, R F, O'Neill, J P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567038/ https://www.ncbi.nlm.nih.gov/pubmed/8319611 |
Ejemplares similares
-
Somatic cell gene mutations in humans: biomarkers for genotoxicity.
por: Albertini, R J, et al.
Publicado: (1993) -
Future research directions for evaluating human genetic and cancer risk from environmental exposures.
por: Albertini, R J, et al.
Publicado: (1996) -
Quantification and molecular characterization of hprt mutants of human T-lymphocytes.
por: Moore, M M, et al.
Publicado: (1993) -
Measurement of chromosomal aberrations, sister chromatid exchange, hprt mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer
por: Jacobson-Kram, David, et al.
Publicado: (1993) -
Population dynamics of normal human blood inferred from somatic mutations
por: Lee-Six, Henry, et al.
Publicado: (2018)